BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-463@pharmaconomics
DTSTAMP:20260707T025022Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:ABBV Catalyst — Skyrizi (risankizumab) (estimated date)
DESCRIPTION:A key catalyst for Skyrizi (risankizumab) (moderately to severely active Crohn's disease (CD)) is expected ~ Dec 31\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000013/abbv-20260331xexhibit991.htm\n\nTrack it: https://pharmaconomics.com/e/463
URL:https://pharmaconomics.com/e/463
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ABBV catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR